Abstract
AbstractBaculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) has been widely used as a bioinsecticide and a protein expression vector. Despite their importance, very little is known about the structure of most baculovirus proteins. Here, we show a 3.2 Å resolution structure of helical cylindrical body of the AcMNPV nucleocapsid, composed of VP39, as well as 4.3 Å resolution structures of both the head and the base of the nucleocapsid composed of over 100 protein subunits. AcMNPV VP39 demonstrates some features of the HK97-like fold and utilizes disulfide-bonds and a set of interactions at its C-termini to mediate nucleocapsid assembly and stability. At both ends of the nucleocapsid, the VP39 cylinder is constricted by an outer shell ring composed of proteins AC104, AC142 and AC109. AC101(BV/ODV-C42) and AC144(ODV-EC27) form a C14 symmetric inner layer at both capsid head and base. In the base, these proteins interact with a 7-fold symmetric capsid plug, while a portal-like structure is seen in the central portion of head. Additionally, we propose an application of AlphaFold2 for model building in intermediate resolution density.
Publisher
Springer Science and Business Media LLC
Subject
General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary
Reference87 articles.
1. Harrison, R. L. et al. ICTV virus taxonomy profile: Baculoviridae. J. Gen. Virol. 99, 1185–1186 (2018).
2. Rohrmann, G. F. Baculovirus Molecular Biology [Internet]. 4th edn (National Center for Biotechnology Information (US), Bethesda (MD), 2019).
3. Kost, T. A. & Kemp, C. W. Fundamentals of Baculovirus expression and applications. Adv. Exp. Med. Biol. 896, 187–197 (2016).
4. van Oers, M. M., Pijlman, G. P. & Vlak, J. M. Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology. J. Gen. Virol. 96, 6–23 (2015).
5. Paul, A., Hasan, A., Rodes, L., Sangaralingam, M. & Prakash, S. Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: Principles, prospects and challenges. Adv. Drug Deliv. Rev. 71, 115–130 (2014).